Prevalence of germline TP53 mutations in HER2+ breast cancer patients

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

(2012) Serena Masciari et al.   BREAST CANCER RESEARCH AND TREATMENT

Early onset HER2-positive breast cancer is associated with germlineTP53mutations

(2011) Amal Melhem-Bertrandt et al.   CANCER

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations

(2010) J. R. F. Wilson et al.   JOURNAL OF MEDICAL GENETICS

The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30

(2009) Ophira M. Ginsburg et al.   Familial Cancer

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

(2009) Julie Tinat et al.   JOURNAL OF CLINICAL ONCOLOGY

High frequency of de novo mutations in Li-Fraumeni syndrome

(2009) K D Gonzalez et al.   JOURNAL OF MEDICAL GENETICS